J&J (JNJ) halted a clinical trial of its antibiotic Doribax after more pneumonia patients...

|By:, SA News Editor

J&J (JNJ) halted a clinical trial of its antibiotic Doribax after more pneumonia patients who took the product died and fewer were cured. Doribax is still considered safe and effective for treating urinary and abdominal infections. (FDA's statement)